Mackay Shields’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Mackay Shields's CELG Position: Q4 2019 in Review
Mackay Shields sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 128,896 shares — an estimated $12.8M sold.
Mackay Shields first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $37.4M in Q1 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Mackay Shields reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Mackay Shields sold 128,896 Celgene Corp shares in Q4 2019, an estimated $12.8M.
- Mackay Shields first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
- Mackay Shields's Celgene Corp position peaked at $37.4M in Q1 2019.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Mackay Shields's 13F filing for Q4 2019, filed 11 Feb 2020.